Project Number 5R01AG065253-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator ABUSHAKRA, SUSAN Principal Investigator First Name SUSAN Principal Investigator Last Name ABUSHAKRA Awardee Organization ALZHEON, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $11,000,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
